ALSERES PHARMACEUTICALS INC /DE 10-Q
Accession 0001193125-13-328326
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 10:01 AM ET
Size
4.5 MB
Accession
0001193125-13-328326
Documents
- 10-Qd561297d10q.htmPrimary
FORM 10-Q
- EX-31.1d561297dex311.htm
EX-31.1
- EX-31.2d561297dex312.htm
EX-31.2
- EX-32.1d561297dex321.htm
EX-32.1
- EX-32.2d561297dex322.htm
EX-32.2
- EX-101.INSalse-20130630.xml
XBRL INSTANCE DOCUMENT
- EX-101.SCHalse-20130630.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.CALalse-20130630_cal.xml
XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
- EX-101.DEFalse-20130630_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
- EX-101.LABalse-20130630_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREalse-20130630_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR8.xml
IDEA: Accounts Payable and Accrued Expenses
- XMLR6.xml
IDEA: Nature of Operations and Basis of Presentation
- XMLR17.htm
IDEA: XBRL DOCUMENT
- XMLR4.htm
IDEA: XBRL DOCUMENT
- XMLR10.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLR24.htm
IDEA: XBRL DOCUMENT
- XMLR29.xml
IDEA: Accounting for Stock-Based Compensation - Summary of Outstanding Stock Options (Detail)
- XMLR18.htm
IDEA: XBRL DOCUMENT
- XMLR34.xml
IDEA: Convertible Preferred Stock - Additional Information (Detail)
- XMLR32.xml
IDEA: Notes Payable and Debt - Summary of Notes Payable to Significant Stockholder (Detail)
- XMLR25.xml
IDEA: Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Detail)
- XMLR38.htm
IDEA: XBRL DOCUMENT
- XMLR27.htm
IDEA: XBRL DOCUMENT
- XMLR26.htm
IDEA: XBRL DOCUMENT
- XMLR34.htm
IDEA: XBRL DOCUMENT
- XMLR19.xml
IDEA: Accounts Payable and Accrued Expenses (Tables)
- XMLR31.htm
IDEA: XBRL DOCUMENT
- XMLR9.xml
IDEA: Net Loss Per Share
- XMLR12.xml
IDEA: Convertible Preferred Stock
- XMLR25.htm
IDEA: XBRL DOCUMENT
- XMLR6.htm
IDEA: XBRL DOCUMENT
- XMLR8.htm
IDEA: XBRL DOCUMENT
- XMLR11.xml
IDEA: Notes Payable and Debt
- XMLR11.htm
IDEA: XBRL DOCUMENT
- ZIP0001193125-13-328326-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLR14.xml
IDEA: Income Taxes
- XMLR2.xml
IDEA: Consolidated Balance Sheets
- XMLR9.htm
IDEA: XBRL DOCUMENT
- XMLR28.htm
IDEA: XBRL DOCUMENT
- XMLR32.htm
IDEA: XBRL DOCUMENT
- XMLR24.xml
IDEA: Summary of Significant Accounting Policies - Additional Information (Detail)
- XMLR10.xml
IDEA: Accounting for Stock-Based Compensation
- XMLR37.htm
IDEA: XBRL DOCUMENT
- XMLR5.xml
IDEA: Consolidated Statements of Cash Flows
- EXCELFinancial_Report.xls
IDEA: XBRL DOCUMENT
- XMLR39.xml
IDEA: Related Party Transaction - Additional Information (Detail)
- XMLR4.xml
IDEA: Condensed Consolidated Statements of Comprehensive Loss
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- XMLR3.htm
IDEA: XBRL DOCUMENT
- XMLR14.htm
IDEA: XBRL DOCUMENT
- XMLR20.xml
IDEA: Accounting for Stock-Based Compensation (Tables)
- XMLR5.htm
IDEA: XBRL DOCUMENT
- XMLR2.htm
IDEA: XBRL DOCUMENT
- XMLR7.xml
IDEA: Summary of Significant Accounting Policies
- XMLR17.xml
IDEA: Subsequent Events
- XMLR16.xml
IDEA: Related Party Transaction
- XMLR27.xml
IDEA: Net Loss Per Share - Additional Information (Detail)
- XMLR18.xml
IDEA: Summary of Significant Accounting Policies (Policies)
- XMLR3.xml
IDEA: Consolidated Balance Sheets (Parenthetical)
- XMLR29.htm
IDEA: XBRL DOCUMENT
- XMLR23.htm
IDEA: XBRL DOCUMENT
- XMLR39.htm
IDEA: XBRL DOCUMENT
- XMLR31.xml
IDEA: Notes Payable and Debt - Additional Information (Detail)
- XMLR35.htm
IDEA: XBRL DOCUMENT
- XMLR36.htm
IDEA: XBRL DOCUMENT
- XMLR30.xml
IDEA: Accounting for Stock-Based Compensation - Summary of Stock Options Outstanding and Exercisable (Detail)
- XMLR13.htm
IDEA: XBRL DOCUMENT
- XMLR21.xml
IDEA: Notes Payable and Debt (Tables)
- XMLR30.htm
IDEA: XBRL DOCUMENT
- XMLR16.htm
IDEA: XBRL DOCUMENT
- XMLR22.xml
IDEA: Fair Value Measurements (Tables)
- XMLR12.htm
IDEA: XBRL DOCUMENT
- XMLR7.htm
IDEA: XBRL DOCUMENT
- XMLR37.xml
IDEA: Fair Value Measurements - Summary of Financial Asset Measured at Fair Value (Detail)
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLR13.xml
IDEA: Commitments and Contingencies
- XMLR38.xml
IDEA: Fair Value Measurements - Additional Information (Detail)
- XMLR23.xml
IDEA: Nature of Operations and Basis of Presentation - Additional Information (Detail)
- XMLR33.htm
IDEA: XBRL DOCUMENT
- XMLR36.xml
IDEA: Income Taxes - Additional Information (Detail)
- XMLR26.xml
IDEA: Accounts Payable and Accrued Expenses - Additional Information (Detail)
- XMLR28.xml
IDEA: Accounting for Stock-Based Compensation - Additional Information (Detail)
- XMLR19.htm
IDEA: XBRL DOCUMENT
- XMLR15.htm
IDEA: XBRL DOCUMENT
- XMLR33.xml
IDEA: Notes Payable and Debt - Summary of Notes Payable to Significant Stockholder (Parenthetical) (Detail)
- XMLR22.htm
IDEA: XBRL DOCUMENT
- XMLR15.xml
IDEA: Fair Value Measurements
- XMLR20.htm
IDEA: XBRL DOCUMENT
- XMLR35.xml
IDEA: Commitments and Contingencies - Additional Information (Detail)
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLR21.htm
IDEA: XBRL DOCUMENT
- XMLR1.xml
IDEA: Document and Entity Information
Issuer
ALSERES PHARMACEUTICALS INC /DE
CIK 0000094784
Related Parties
1- filerCIK 0000094784
Filing Metadata
- Form type
- 10-Q
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 10:01 AM ET
- Size
- 4.5 MB